Candel Therapeutics (CADL) shifts to late-stage oncology with CAN-2409 Phase III wins and BLA catalyst. Read here for a ...
T]he Advance Ohio Higher Education Act ("S.B. 1") … touches upon, among other things, the discontinuation of offices and orientation programs related to diversity, equity, and inclusion ("DEI") at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results